Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Invested Capital (2016 - 2025)

Abeona Therapeutics has reported Invested Capital over the past 15 years, most recently at $171.4 million for Q4 2025.

  • Quarterly results put Invested Capital at $171.4 million for Q4 2025, up 243.17% from a year ago — trailing twelve months through Dec 2025 was $171.4 million (up 243.17% YoY), and the annual figure for FY2025 was $171.4 million, up 243.17%.
  • Invested Capital for Q4 2025 was $171.4 million at Abeona Therapeutics, down from $180.1 million in the prior quarter.
  • Over the last five years, Invested Capital for ABEO hit a ceiling of $180.1 million in Q3 2025 and a floor of -$8.9 million in Q1 2024.
  • Median Invested Capital over the past 5 years was $48.3 million (2021), compared with a mean of $60.9 million.
  • Peak annual rise in Invested Capital hit 707.52% in 2024, while the deepest fall reached 147.39% in 2024.
  • Abeona Therapeutics' Invested Capital stood at $47.0 million in 2021, then crashed by 43.02% to $26.8 million in 2022, then tumbled by 44.6% to $14.8 million in 2023, then surged by 236.96% to $50.0 million in 2024, then soared by 243.17% to $171.4 million in 2025.
  • The last three reported values for Invested Capital were $171.4 million (Q4 2025), $180.1 million (Q3 2025), and $169.1 million (Q2 2025) per Business Quant data.